Ethiopian Public Health Institute Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2015
NCT02363985
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ethiopian Public Health Institute

Active Ingredients

Drugs in Phase 3 Trials (2)

primaquine (1 trial)

tafenoquine succinate (arakoda) (1 trial)

Drugs in Other Trials (1)

vitamin a (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 3)

Malaria, Vivax (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3